Ancestral and consensus envelope immunogens for HIV-1 subtype C. - Wikidata - awgldk - TriplyDB

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

http://www.wikidata.org/entity/Q34539222

about

Design and pre-clinical evaluation of a universal HIV-1 vaccine Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine A lectin isolated from bananas is a potent inhibitor of HIV replication Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth New concepts in HIV-1 vaccine development Ancestral Reconstruction A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data.HIV-1 group M conserved elements vaccine.Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains.Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual.Characterization of a putative ancestor of coxsackievirus B5.Generation and characterization of an HIV-1 subtype C transmitted and early founder virus consensus sequence.Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.The thermostability and specificity of ancient proteins.Evidence for henipavirus spillover into human populations in Africa.Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaques Dissecting the dynamics of HIV-1 protein sequence diversity.DNA vaccines: ready for prime time?Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination.Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.AAV ancestral reconstruction library enables selection of broadly infectious viral variants.Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

P2860

Q21092234-02E1C0CF-2557-426D-85B8-F25164E62D12 Q21131325-72796232-7A6A-4196-A799-CC9A25530C0F Q24629155-0B5C9C12-47A8-4627-81CB-257FFF4CC308 Q27676728-3901DBE2-781E-4D72-8067-F0533C49843E Q28067027-6C778B6D-7634-484B-B648-28C54E16F08C Q28596371-8B4F8E24-0F8B-452E-B078-F6F2E5764101 Q28743092-8E86C768-7BEC-47DA-8463-59ABC69635E9 Q30228657-F7414412-9897-4416-AD03-4CFCC1ECA545 Q30379200-37DC4512-8BD2-4547-BF4F-DE88169DF17D Q30781299-42D18270-7DAC-46AA-8E59-8E18D23524A1 Q33308246-4B686A1A-BA62-4D00-8B0C-AE6626B22C02 Q33323199-F8FCFB94-82C0-4233-BE9B-473E3E6E89D8 Q33648910-7965F218-69BA-4EBB-BE7D-EA0A90E331F9 Q33839456-404540F1-DA2D-44F4-A163-85D116401367 Q33872445-5D006D81-87A8-424B-8905-32E096C009B8 Q33912373-409273C0-55A7-4243-AA72-21D8EA7475BF Q34120873-EFEFD116-2C9F-40E5-9C5A-DE231DB93D40 Q34266252-A52EAC33-83BB-4B8F-8F5E-B5D41AB3B5E8 Q34300812-BE005815-3797-4430-A8FD-6F6759CF5491 Q34423446-BCC35173-2B59-4D04-AE2C-D53821E56929 Q34530545-918D08B3-3137-43FD-BA89-4AFE8799D101 Q34541512-9E97104D-112F-47EC-A64F-81C03B98F8B7 Q34663118-04E7B59C-686D-43AD-A1DA-29D6DCB8AD40 Q34672589-3577548E-93C3-48C2-9600-0A5F923E182E Q34824179-2E507694-6107-4C7A-B64A-B82443B96A5F Q35034268-493F99AA-DC83-4912-9D24-8E72D65474BE Q35076717-2C9ABE56-89BF-4008-95FF-83443E4EC12B Q35076748-C4FEDCE2-F573-434F-9833-EB4ECF427DA4 Q35093052-1601C0C0-86B7-482B-8965-E534507C1ED5 Q35192641-BE07612D-6E4C-4C84-A158-3C269DA5E61B Q35208657-B3D65CC9-7E96-4F1B-BE31-139DD8FB147D Q35666057-1BD35B4B-514B-4961-88BC-487F07BCDA8C Q35695082-E6080E11-2877-48CF-9D7A-2CBCFBCCA9F6 Q35760486-621249F3-06CF-4444-9F8F-648095158836 Q35862305-950F2B0E-2E60-4B0D-A9F2-727FE8CD70B3 Q35933555-CE9E6682-22AD-4A94-8B0E-22290D23F97A Q35943810-6A845031-275D-44B0-84A2-21F5EBB1C2AE Q35983587-0E814167-C605-46B7-A36A-D047C7DA9928 Q36083061-64CF02FC-C556-4F5B-B153-4FE7DCC27786 Q36099119-DAF80F05-868D-43F4-8AEA-72E0BAC4DAFE

P2860

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

http://www.wikidata.org/entity/Q34539222

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@ast

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@en

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@nl

type

label

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@ast

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@en

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@nl

prefLabel

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@ast

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@en

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@nl

P1433

Q34539222-50824887-7DA8-407A-A76A-9AA0943D6729

P1476

Q34539222-0350F62E-F40E-4F23-8E80-48A92943A096

P2093

Q34539222-036C2A8C-FAC3-4FF5-A3D3-A134F3FB4B8C

Q34539222-12FCB8A3-A597-41D0-A5FC-61FCE199FD23

Q34539222-17109B63-E949-484C-9363-941BF624CAF6

Q34539222-42FD7487-D2A7-4040-B609-A6F811EF5317

Q34539222-4D866FD6-364E-4FC5-8266-9496B4D81897

Q34539222-5241B2CE-8599-4DF6-B770-EF597DF60382

Q34539222-554CAC9C-3E11-4FAA-B022-247CE12D68FA

Q34539222-70993D40-A1F7-4139-943F-133CCC01B0F5

Q34539222-8D3A7243-E776-43AB-8A46-50C50638B983

P304

Q34539222-9B5C7934-358C-4C54-A8D2-0E3864BA1FC7

P31

Q34539222-0CD7B404-E811-4C9E-A674-BA3F02F588CA

P356

Q34539222-E4886AA8-FD02-47B0-979E-5931DF2BB8B5

P407

Q34539222-4BAAAFD6-1853-4503-92B6-70DC0FA314C9

P433

Q34539222-6ED03ADA-7EFB-43C1-8D28-1C4EAE1D20AB

P478

Q34539222-5925759A-1F99-4673-B3E1-93BFA35A3297

P50

Q34539222-0B5B30C3-16DA-4C6B-A2AA-1502233ECA0F

Q34539222-A6E183BA-3577-4BFE-8901-83E77B25CAA8

Q34539222-D4E28649-28DC-4683-A674-D393D6D7C416

Q34539222-D5CCB29E-292C-47E1-93F5-C0EC2C88B14A

Q34539222-FB1123EF-232A-43F0-ABD4-F653BBB8C9A5

P577

Q34539222-CEDF2C41-C3AE-41E8-B334-FFEE8BEC2A61

P5875

Q34539222-B2C53E1D-4B7D-4502-AF46-8D2CB2B5A789

P698

Q34539222-E8958F93-0E98-4F55-B64B-69463ED28829

P356

J.VIROL.2006.05.011

P1433

P1476

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

@en

P2093

Denise L Kothe

http://www.w3.org/2001/XMLSchema#string

Eric A Weaver

http://www.w3.org/2001/XMLSchema#string

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Julie M Decker

http://www.w3.org/2001/XMLSchema#string

Kenneth P Zammit

http://www.w3.org/2001/XMLSchema#string

Maria G Salazar

http://www.w3.org/2001/XMLSchema#string

Yalu Chen

http://www.w3.org/2001/XMLSchema#string

Yingying Li

http://www.w3.org/2001/XMLSchema#string

Zhiping Weng

http://www.w3.org/2001/XMLSchema#string

P304

438-449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2006.05.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Frederic Bibollet-Ruche

Beatrice H. Hahn

P577

2006-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7002683

http://www.w3.org/2001/XMLSchema#string

P698

16780913

http://www.w3.org/2001/XMLSchema#string